EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access

Assessing the Relationship Between Steatotic Liver Disease and Barrett’s Esophagus: A Cross-Sectional Analysis of 5507 Screening Participants

Nikolaus Götz, Andreas Völkerer, Hannah Hofer, Sarah Wernly, Franz Singhartinger, Ewald Wöll, Elmar Aigner, Maria Flamm, Christian Datz, Bernhard Wernly

Zeitschrift für Gastroenterologie · 01.05.2026 · 64 (05) · 470-477

DOI: 10.1055/a-2763-8210 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.05.2026. Verfasst von Nikolaus Götz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Paracelsus Medical University, Salzburg, Austria, Salzburg. Hauptthemen laut MEDLINE: Barrett Esophagus, Fatty Liver. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Barrett’s esophagus (BE) is the main precursor of esophageal adenocarcinoma (~2% prevalence in Western adults). Steatotic liver disease (SLD), affecting ~25% of adults, is linked to systemic inflammation, but its relationship with BE is unclear.

Methods

In the population-based Salzburg Colon Cancer Prevention Initiative (2007–2020), we analyzed 5507 asymptomatic screening participants. SLD was diagnosed by ultrasound and classified as MASLD or MetALD; BE was confirmed endoscopically and histologically. Associations were assessed using multivariable logistic regression adjusting for demographic, metabolic, and clinical factors.

Results

SLD was present in 2550 participants and clustered with diabetes and metabolic syndrome. BE was found in 62 individuals (1.0% without SLD, 1.5% with MASLD, 1.1% with MetALD; P = 0.28). After adjustment, MASLD (OR 1.28; 95% CI 0.74–2.21) and MetALD (OR 0.66; 95% CI 0.16–2.85) were not significantly associated with BE. Female sex was protective (OR 0.26; 95% CI 0.13–0.50), while hiatal hernia increased BE risk (OR 2.05; 95% CI 1.16–3.60).

Conclusion

In this population-based cohort, MASLD and MetALD were not clearly associated with BE. Current data do not support incorporating SLD status into BE screening algorithms, although modest risk increases cannot be ruled out.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Barrett EsophagusFatty LiverHumansFemaleMaleCross-Sectional StudiesMiddle AgedRisk FactorsAgedPrevalenceGermanyComorbidityMass ScreeningHernia, Hiatal

Autor:innen und Institutionen

  • Paracelsus Medical University, Salzburg, Austria, Salzburg.

Zitieren

APA

Götz, N., Völkerer, A., Hofer, H., Wernly, S., Singhartinger, F., Wöll, E., Aigner, E., Flamm, M., Datz, C., & Wernly, B. (2026). Assessing the Relationship Between Steatotic Liver Disease and Barrett’s Esophagus: A Cross-Sectional Analysis of 5507 Screening Participants. Zeitschrift für Gastroenterologie, 64(05), 470-477. https://doi.org/10.1055/a-2763-8210

Vancouver

Götz N, Völkerer A, Hofer H, Wernly S, Singhartinger F, Wöll E, et al. Assessing the Relationship Between Steatotic Liver Disease and Barrett’s Esophagus: A Cross-Sectional Analysis of 5507 Screening Participants. Zeitschrift für Gastroenterologie. 2026;64(05):470-477. doi:10.1055/a-2763-8210

BibTeX
@article{Gtz2026,
  author = {Götz, Nikolaus and Völkerer, Andreas and Hofer, Hannah and Wernly, Sarah and Singhartinger, Franz and Wöll, Ewald and Aigner, Elmar and Flamm, Maria and Datz, Christian and Wernly, Bernhard},
  title = {Assessing the Relationship Between Steatotic Liver Disease and Barrett’s Esophagus: A Cross-Sectional Analysis of 5507 Screening Participants},
  journal = {Zeitschrift für Gastroenterologie},
  year = {2026},
  volume = {64},
  number = {05},
  pages = {470--477},
  doi = {10.1055/a-2763-8210}
}
Kostenlos starten →